Klotho Neurosciences, Inc. Warrant (KLTOW)

🚫 Klotho Neurosciences, Inc. Warrant does not pay dividends

Company News

Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets
Benzinga • Prnewswire • July 22, 2025

Klotho Neurosciences has partnered with AAVnerGene to enhance gene therapy manufacturing processes for neurological disease treatments, focusing on more efficient and cost-effective AAV vector technologies.

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco
GlobeNewswire Inc. • N/A • January 8, 2025

Klotho Neurosciences, a biotechnology company focused on developing cell and gene therapies for neurodegenerative diseases, will present at the Biotech Showcase 2025 conference during the J.P. Morgan Healthcare Week in San Francisco.